Describe the basic structure of HIV.
Describe the basics of HIV genes.
LTR: long terminal repeats that act like promoter
Gag, Pol, env: code for structural proteins of virus and enzymes required for replication
vif, vpr, tat, rev, vpu, nef: encode proteins that regulate viral life cycle and contribute to host cell injury
Why do the HIV particles in infected indivs vary so much from person to person?
-High mutation rate (106 > TCR genes) partly because doesn’t have nucleic acid repair mechanism
-Marked genomic variability
-Selective target cell tropism
MØ’s (CD4 & CCR5)
T-cells (CD4 & CXCR4)
T-cells (CD4 & CXCR4 or CCR5)
-In vivo virulence variability
Briefly, what is the life cycle of HIV?
What are ways in which HIV spreads in the body?
What happens in the acute phase of HIV infection?
What happens in the chronic phase of HIV infection?
How does HIV evade the host immune response?
-low gp120 spike density on virion surface
-conformational shielding of critical epitopes, critical components of gp120 folded into the inside of protein
-envelop heterogeneity and glycosylation: higher glycan density promotes viral ability to evade antibodies
-preferential infection of HIV specific T cells: loss of CD4+ HIV specific response
-role of HIV regulatory gene products, e.g.:
Vpr: suppresses Il12 production from macrophages
Vif: inhibits APOBEC3 which edits retroviral cDNA and induces fatal mutations
Nef: decresases CD4 expression, blocks apoptosis
Vpu: inhibits tethering (prevents HIV release from cell) and NKT cell activation
-emergence of escape mutants that overcome host capacity to generate cytotoxic lymphocytes
-virion expression of host complement regulatory proteins
-TREX1 inhibits innate immune response to reversely transcribed HIV DNA
-chronic infection exhausts effector T cells
-Macrophages and T cells “archive” virus
How does HIV induce immune deficiency?
-Rapid, early destruction of ~50% mucosal memory T-cells
-CD4+ T-cell depletion: mechanistic examples:
Direct cytotoxicity – activation of DNA- dependent protein kinase during integration
Syncytia formation: fusion of infected cell and uninfected cell to b/c nonfunctional giant cell
-Decreased BM production of lymphoid precursors
-Decreased thymic output of “new” T-cells
-Later destruction of lymph node architecture–> impaired clonal expansion
How does HIV induce immune deficiency?
-Rapid, early destruction of ~50% mucosal memory T-cells
-CD4+ T-cell depletion: mechanistic examples:
Direct cytotoxicity – activation of DNA- dependent protein kinase during integration
Syncytia formation: fusion of infected cell and uninfected cell to b/c nonfunctional giant cell
-Decreased BM production of lymphoid precursors
-Decreased thymic output of “new” T-cells
-Later destruction of lymph node architecture–> impaired clonal expansion
Outline the pathogenesis of HIV.
Outline the pathogenesis of HIV.
What is the pathophysiology of HIV?
What is the pathophysiology of HIV?
What are the current epidemiological trends of HIV?
What are the current epidemiological trends of HIV?
What are the HIV screening recommendations put out by the CDC?
-Routine for all persons ages 13-64
-Additionally test all patients:
Tested or treated for an STD
Initiating TB tx
Pregnant women
Women with undocumented HIV status at L&D
-Repeat screening annually for high risk
-Opt-out
What are the HIV screening recommendations put out by the CDC?
-Routine for all persons ages 13-64
-Additionally test all patients:
Tested or treated for an STD
Initiating TB tx
Pregnant women
Women with undocumented HIV status at L&D
-Repeat screening annually for high risk
-Opt-out
What are the diagnostic tests for HIV?
What are the diagnostic tests for HIV?
What are the acute clinical manifestations of HIV infection?
-fever
-lymphadenopathy
-pharyngitis
-rash
-myalgia or arthralgia
-diarrhea
-headache
-nausea and vomiting
Onset <6 weeks, duration 2-8 weeks
What are the benefits and risks of starting early ART therapy?
-Benefits:
Control of viral replication easier to achieve/maintain
Delay or prevention of immunodeficiency
Lower risk of resistance
Decreased risk of HIV transmission
Reduced risk of non-AIDS diseases (cancer, CHD)
-Risks:
Drug-related reduction in quality of life
Cumulative drug-related adverse events
Development of drug resistance in those with poor adherence
Limitation of future treatment options
Increased risky behavior
What are the chronic manifestations of symptomatic HIV?
Wasting Thrush Fever for greater than two weeks Diarrhea for greater than 1 month ITP Oral Hairy Leukoplakia Herpes Zoster -In women, additionally can have: Recurrent Vulvovaginal Candidiasis Cervical Dysplasia Carcinoma in situ of the cervix Pelvic Inflamatory Disease (P.I.D) -Associated with chronic HIV Onychomycosis of the fingernails Seborrheic Dermatitis Persistant or severe fungal infections of the skin Syphillis, neurosyphillis, or other STI’s
What are important Protease inhibitors (PIs) drugs? What are their side effects?
PIs have higher genetic barrier to resistance